Lunit to present 15 studies, with an unprecedented 13 accepted as oral presentations, marking a significant milestone in ...
Metronomic capecitabine plus an aromatase inhibitor improved survival outcomes in hormone receptor-positive, HER2-negative ...
MedStar Breast Health Program Director Dr. Lucy De La Cruz joined Good Day DC with some important information on how early ...
Perimeter Medical Imaging AI, Inc. begins trading today on OTCQX under the symbol “PYNKF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on ...
Gain insights into the U.S. market, valued at $262.2 Million in 2024, and China, forecasted to grow at an impressive 17.7% ...
New solutions further enhance F5 platform with capabilities that reduce complexity, simplify operations, and strengthen security for every app.
About a year ago, India minted its first AI unicorn — Krutrim — which aims to build the country’s first complete AI computing ...
NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer ...
New brain-inspired hardware, architectures and algorithms could lead to more efficient, more capable forms of AI.
HER2 (also known as ERBB2) is a key oncogene in breast cancer and is found in 2–4% of patients with non-small-cell lung ...
Learn about the new AI collaboration between Memorial Sloan Kettering Cancer Center and Amazon Web Services, and its potential to transform cancer care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results